Back to search

In vitro pharmacodynamic evaluation of VP-16-213 and implications for chemotherapy

Data up to Jan 2025

Published1987
Citations63
References20

Total Citations Per Year

Abstract

References (20)

Quantitation of Differential Sensitivity of Human-Tumor Stem Cells to Anticancer Drugs

1978 • 982 citations

Association between human tumor colony-forming assay results and response of an individual patient's tumor to chemotherapy

1981 • 378 citations

Etoposide (VP-16–213)

1985 • 361 citations

Prospective clinical trial of a human tumor cloning system.

1983 • 340 citations

Etoposide (VP-16-213)

1979 • 151 citations

Pharmacokinetics of high-dose etoposide (VP-16-213) administered to cancer patients.

1984 • 149 citations

Therapeutic trials with VP-16-213 and VM-26: active agents in small cell lung cancer, non-Hodgkin's lymphomas, and other malignancies.

1979 • 142 citations

VM 26 and VP 16–213: A comparative analysis

1977 • 122 citations

Pharmacokinetics of VP16-213 given by different administration methods

1982 • 121 citations

High-dose VP-16-213 and autologous bone marrow transplantation for refractory malignancies: a phase I study.

1983 • 107 citations

Pharmacokinetics of teniposide (VM26) and etoposide (VP16-213) in children with cancer

1982 • 107 citations

High-dose teniposide for refractory malignancies: a phase I study.

1986 • 72 citations

High-dose VP-16-213 monotherapy for refractory germinal malignancies: a phase II study.

1984 • 68 citations

Pharmacokinetics of etoposide (VP16) in children and adolescents with refractory solid tumors.

1984 • 63 citations

The clinical pharmacology of VM26 and VP16-213

1982 • 60 citations

A phase I trial of continuous infusion VP16-213 (Etoposide)

1982 • 51 citations

Comparative cytotoxic and cytokinetic effects of the epipodophyllotoxins 4'-demethylepipodophyllotoxin-9-(4,6-O-2-ethylidene-beta-D-glucopyranoside) and 4'-demethylepipodophyllotoxin-9-(4,6-O-2-thenylidene-beta-D-glucopyranoside) and their metabolites on human leukemic lymphoblasts.

1983 • 43 citations

Randomized dose-response evaluation of etoposide in small cell carcinoma of the lung: A southeastern cancer study group trial

1987 • 28 citations

Phase I study of VP-16-213 (Etoposide) administered as a continuous 5-day infusion.

1981 • 18 citations

Evaluation of drug efficacy inVitro using human small cell carcinoma of the lung spheroids

1985 • 9 citations

Cited By (0)

No citing papers found in database

In vitro pharmacodynamic evaluation of VP-16-213 and implications for chemotherapy (1987) – Cancer Chemotherapy and Pharmacology | Metascience Observatory Explorer